The diseases we cause: Iatrogenic illness in a department of internal medicine

European Journal of Internal Medicine

Volumn 18, Issue 5, 2007, Pages 391-399

  Madeira, Sofia ^a   Melo, Miguel ^a   Porto, João ^a   Monteiro, Sílvia ^a   Pereira de Moura, J M ^a   Alexandrino, M B ^a   Moura, J J Alves ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Iatrogenic disease; Incidence; Internal medicine department; Prospective study; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

AGING; ARTICLE; CAUSE OF DEATH; CHRONIC DISEASE; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFECTION; INTERNAL MEDICINE; METABOLIC DISORDER; QUESTIONNAIRE; RISK FACTOR;

EID: 34547692966     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.12.009     Document Type: Article

References (37)

1. Cerecedo Cortina Vicente B. Iatrogenia y error medico. Rev Med Hosp Gen Mex 60 2 (1997) 75-83
2. Alhalel Gabay B. Polifarmacia, Iatrogenia y Reacciones Adversas por Medicamentos en el Adulto Mayor. Diagnóstico: Revista Médica de la Fundación Instituto Hipólito Unanue vol. 42(3) (May-Jun 2003) 117-121
3. Forster A., Clark H., Menard A., Dupuis N., Chernish R., Chandok N., et al. Adverse events among medical patients after discharge from hospital. CMAJ 170 3 (Feb 3 2004) 345-349
4. Starfield B. Is US really the best in the world?. JAMA 284 4 (Jul 26 2000) 483-485
5. Zhan C., and Miller M. Excess length of stay, charges and mortality attributable to medical injuries during hospitalization. JAMA 290 14 (Oct 8 2003) 1868-1874
6. Kaushal R., Bates D., Landrigan C., McKenna K., Clapp M., Frederico F., et al. Medication errors and adverse drug events in paediatric inpatients. JAMA 285 16 (Apr 25 2001) 2114-2120
7. Diez Jarilla J., Munoz Bellido J., and de Castro del Pozo S. Iatrogenic pathology in an internal medicine service-I: global and non-drug iatrogenic pathology. Med Clin (Barc) 87 2 (Jun 7 1986) 58-61
8. Brennan T., Leape L., Laird N., Hebert L., Localio A., Lawthers A., et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard medical practice study I. NEJM 324 6 (Feb 7 1991) 370-376
9. Leape L., Brennan T., Laird N., Lawthers A., Localio A., Barnes B., et al. The nature of adverse events in hospitalized patients: results of the Harvard medical practice study II. NEJM 324 6 (Feb 7 1991) 377-384
10. Sampereiz Legarre A., Rubio Obanos M., Escolar Castellon F., Alonso Martinez J., Lanas Arbeloa A., and Ayuso Blanco T. A iatrogenic pathology study in an internal medicine service. Rev Clin Esp 194 6 (Jun 1994) 457-463
11. Fradet G., Legac X., Charlois T., Ponge T., and Cottin S. Iatrogenic drug-induced diseases, requiring hospitalization, in patients over 65 years of age. 1-year retrospective study in an internal medicine department. Rev Med Interne 17 6 (1996) 456-460
12. Steel K., Gertman P., Crescenzi C., and Anderson J. Iatrogenic illness on a general medical service at a university hospital. NEJM 304 11 (Mar 12 1981) 638-642
13. Weingart S., and Iezzoni L. Looking for medical injuries where the light is bright. JAMA 290 14 (Oct 8 2003) 1917-1919
14. Queneau P., Chabot J., Rajaona H., Boissier C., and Grandmottet P. Iatrogenic illness observed in the hospital environment-I: a report of 109 cases collected in a cross-sectional APNET study. Bull Acad Natl Med 176 4 (Apr 1992) 511-526 discussion 526--9
15. Moore N., Lecointre D., Noblet C., and Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45 3 (Mar 1998) 301-308
16. Lagnaoui R., Moore N., Fach J., Longy-Boursier M., and Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 56 2 (May 2000) 181-186
17. Gurwitz J., Field T., Harrold L., Rothschild J., Debellis K., Seger A., et al. Incidence of adverse drug events among older persons in the ambulatory setting. JAMA 289 (2003) 1107-1116
18. Gonzales-Martin G., Yanez L., and Valenzuela F. Adverse drug reactions among hospitalized elderly patients: prospective study. Rev Med Chil 125 10 (Oct 1997) 1129-1136
19. de la Sierra A., Cardellach F., Cobo E., Bove A., Roige M., Santos M., et al. Iatrogenic illness in a department of general internal medicine: a prospective study. Mt Sinai J Med 56 4 (Sep 1989) 267-271
20. Husi F., and Stalder H. Self-monitoring of physicians for the detection of iatrogenic diseases. Schweiz Med Wochenschr 116 11 (Mar 15 1986) 346-351
21. Lepori V., Perren A., and Marone G. Adverse internal medicine drug effects at hospital admission. Schweiz Med Wochenschr 129 24 (Jun 19 1999) 915-922
22. Lakshmanan M., Hershey C., and Breslau D. Hospital admissions caused by iatrogenic disease. Arch Int Med 146 10 (Oct 1 1986)
23. Wiffen P., Gill M., Edwards J., and Moore E. Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier extra (Jun 2002)
24. Trunet P., Le Gall J., Lhoste F., Regnier B., Saillard Y., Carlet J., et al. The role of iatrogenic disease in admissions to intensive care. JAMA 244 23 (Dec 12 1980)
25. Lee C.T., Guo H.R., and Chen J.B. Hyponatremia in the emergency department. Am J Emerg Med 18 3 (May 2000) 264-268
26. Rothschild J., Landrigan C., Cronin J., Kaushal R., Lockley S., Burdick E., et al. The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 33 8 (Aug 2005) 1694-1700 comment 1860--2
27. Bouhaja B., Mermech M., Mestiri T., Ben Ayed M., Dhaouadi M., and Ben Ammar M. Iatrogenic disease in the intensive care unit: a prospective study. Reanim Urgences 8 4 (Jul 1999) 319-326
28. Alonso Martinez J.L., Llorante Diez B., Echegaray Agara M., Urbieta Echezarreta M.A., and Gonzalez Arencibia C. Hospital readmission in internal medicine. An Med Interna 18 5 (May 2001) 248-254
29. Dormann H., Neubert A., Criegee-Rieck M., Egger T., Radespiel-Troger M., Azaz-Livshits T., et al. Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 255 6 (Jun 2004) 653-663
30. Lazarou J., Pomeranz B., and Corey P. Incidence of Adverse Drug Reactions in hospitalized patients. JAMA 279 15 (Apr 15 1998) 1200-1205
31. Runciman W., Webb R., Helps S., Thomas E., Sexton E., Studdert D., et al. A comparison of iatrogenic injury studies in Australia and the USA. II: Reviewer behavior and quality of care. Int J Qual Health Care 12 5 (Oct 2000) 379-388
32. Roblot P., de Bayser L., Barrier J., Marechaud R., and Becq-Giraudon B. Primum non nocere, a forgotten adage at times. Apropos of 106 cases of iatrogenic pathologies collected in a year. Rev Med Interne 14 10 (1993) 950
33. Goute D., Gonon N., Roblot P., Marechaud R., and Sudre Y. Iatrogenic drug pathology on admission in a department of internal medicine; results of a 6-month prospective study. Ann Med Interne (Paris) 138 2 (1987) 148-149
34. McGavock H. Prescription-related illness: a scandalous pandemic. J Eval Clin Pract 10 4 (Nov 2004) 491-497
35. Zamir D., Polychuck I., Leibovitz I., Reiblat T., Zamir C., and Scharf S. Nosocomial infections in internal medicine departments. Harefuah 142 4 (Apr 2003) 265-268
36. Munar Ques M., Font Gelabert A., Feliu Mazaira L., Mut Mandilego A., Vidal Mullor R., Vich Martorell C., et al. Nosocomial diseases in a general medicine service. Med Clin (Barc) 89 15 (Nov 1987) 625-630
37. Riedinger J., and Robbins L. Prevention of iatrogenic illness: adverse drug reactions and nosocomial infections in hospitalized older adults. Clin Geriatr Med 14 4 (Nov 1998) 681-698